Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs
Submitted: 1 August 2020
Accepted: 15 February 2021
Published: 19 April 2021
Accepted: 15 February 2021
Abstract Views: 3476
PDF: 487
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- C. Ferrone, R. Andracco, M.A. Cimmino, Calcium pyrophosphate deposition disease: clinical manifestations , Reumatismo: Vol. 63 No. 4 (2011): Special issue • Microcrystalline Arthritis
- S. Soldano, P. Montagna, R. Brizzolara, C. Ferrone, A. Parodio, A. Sulli, B. Seriolo, B. Villaggio, M. Cutolo, Endothelin receptor antagonists: effects on extracellular matrix synthesis in primary cultures of skin fibroblasts from systemic sclerosis patients , Reumatismo: Vol. 64 No. 5 (2012)
- F. Schiavon, M. Favero, V. Carraro, L. Riato, Septic arthritis: what is the role for the rheumatologist? , Reumatismo: Vol. 60 No. 1 (2008)
- F. Atzeni, P. Sarzi-Puttini, Early rheumatoid arthritis , Reumatismo: Vol. 59 No. 2 (2007)
- C. Botsios, P. Sfriso, A. Furlan, P. Ostuni, M. Biscaro, U. Fiocco, S. Todesco, L. Punzi, Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis , Reumatismo: Vol. 59 No. 1 (2007)
- Giuseppe D'Alessandro, Maria Rosaria Bianco, Spiridon Politis, Celestino Ferrandina, Giuseppe Rossi, Emanuele Altomare, Case report: AREB in a patient with rheumatoid arthritis treated with methotrexate and infliximab , Reumatismo: Vol. 58 No. 1 (2006)
- G. Zamogna, M. Parodi, B. Bartolini, D. Schettini, G. Minetti, M. D'Auria, E. Silvestri, G. Garlaschi, M.A. Cimmino, Dynamic contrast-enhanced magnetic resonance imaging of the wrist in early arthritis , Reumatismo: Vol. 60 No. 4 (2008)
- T. Ziglioli, C. Bazzani, M. Filippini, S. Zingarelli, A. Giugno, R. Gorla, Early rheumatoid arthritis: a prospective study on how to induce the remission , Reumatismo: Vol. 60 No. 2 (2008)
- G. La Montagna, R. Tirri, R. Vitiello, D. Malesci, R. Buono, G. Mennillo, G. Valentini, Safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice , Reumatismo: Vol. 58 No. 4 (2006)
- I. Cavazzana, F. Franceschini, E. Danieli, M. Frassi, M. Vianelli, R. Gorla, P. Airò, R. Cattaneo, Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies , Reumatismo: Vol. 57 No. 4 (2005)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
You may also start an advanced similarity search for this article.